Find your path to Alan
17 people in our graph share verified history with Alan — schools, employers, funds. One of them is your warm intro.
James ZhaounlockedAlan: together at LYFE Capital
×11Alan: together at LYFE Capital
About
Singapore-based, Alan Wang combines Bristol Myers Squibb corporate strategy and healthcare consulting experience to lead cross‑border Asia–U.S. medtech deals (Kangji, EDGE, Noah, Fong's Engineering) with a data‑driven analytical approach.
Invests in
BiotechData & InfrastructureHealthtechMedical DevicesRobotics
Colleagues at LYFE Capital
Alvin Koh
Investment Principal and Senior Director, APAC Business Development at LYFE Capital
David Liu
Director of Investor Relations at LYFE Capital
Derek Yuan
Partner at LYFE Capital
Fong Ming Koh
Principal at LYFE Capital
Frances Chovanec
Managing Director at LYFE Capital
Jack Chen
Partner at LYFE Capital
James Zhao
Founder and Partner at LYFE Capital
.avif)
Jing Xu
Principal at LYFE Capital
Frequently asked questions
- Who is Alan Wang?
- Singapore-based, Alan Wang combines Bristol Myers Squibb corporate strategy and healthcare consulting experience to lead cross‑border Asia–U.S. medtech deals (Kangji, EDGE, Noah, Fong's Engineering) with a data‑driven analytical approach.
- Where does Alan Wang work?
- Alan Wang is Managing Director at LYFE Capital.
- What does Alan Wang invest in?
- Alan Wang invests in Biotech, Data & Infrastructure, Healthtech, Medical Devices, Robotics.